Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

Source:http://linkedlifedata.com/resource/pubmed/id/17088570

J. Clin. Oncol. 2006 Dec 1 24 34 5366-72

Download in:

View as

General Info

PMID
17088570